The microbiota as seen by the experts
En parallèle de la venue de Martin J. Blaser sur Bordeaux pour sa cérémonie Honoris Causa, une conférence est organisée au PJJ (place Pey Berland), amphithéâtre Deguit, le 09 mai de 15 à 18h.
THE MICROBIOTA AS SEEN BY THE EXPERTS
Monday may-09-2022
15h-18h-Amphitéatre Deguit
Pôle Juridique et Judiciaire, place Pey Berland, 33000 Bordeaux.
15h-Introduction: Mr le Directeur Général-CHU Mr Yann Bubien
Plenary talks: Microbiota view from international experts
(2 talks of 30 min each + 1 talk of 20 min)
-Pr Maria Gloria Dominguez Bello, Department of Biochemistry and Microbiology, Robert Wood Johnson Medical School, Rutgers university, New Jersey: “The human microbiome in the anthropocene.”
-Pr Martin J Blaser, Departments of Medicine and Pathology & Laboratory Medicine, RBHS, Robert Wood Johnson Medical School, Rutgers university, New Jersey: “The double-edged sword of antibiotics.”
-Pr Claire Andrejak, CHU de Amiens, service de Pneumologie:« Pulmonary Microbiote, what do we know (or don’t know) in 2022 ?”
Break: 30min
Symposium: "The microbiota in Bordeaux: crossed views of senior researchers"
(2 talks of 15 min each)
-Pr Maya Saleh, Immunoconcept, CNRS UMR 5164 – University of Bordeaux: « Exploring the role of the microbiome in patients response to cancer immunotherapies».
-Pr David Laharie, CHU de Bordeaux, service de gastroentérologie: « Deciphering host-microbiota crosstalk in acute severe ulcerative colitis »
Symposium: "The microbiota in Bordeaux: crossed views of young scientific researchers"
(4 talks of 10 min each)
- Marine Jauvain, INSERM U1312, BRIC, Team 4, University of Bordeaux and CHU de Bordeaux, Laboratoire de Bactériologie, CNR des Campylobacters et des Hélicobacters: Metformin modifies the gut microbiota of mice infected with Helicobacter pylori.
- Julie Giraud, Immunoconcept, CNRS UMR 5164 – University of Bordeaux: A role of intra-tumoral bacteria in HCC?
- Eléna Charpentier - Mycology department, Bordeaux CHU & Inserm U1045 : Mycobiota: An emerging component that FANCy helps to decipher by predicting the functional potential of a fungal community.
- Raphael Enaud - Paediatric CRCM, Bordeaux CHU & Inserm U1045: Impacts of CFTR modulators on the airway and gut mycobiota-microbiota in patients with cystic fibrosis.
De 15:00 à 18:00
Les contenus partageant les mêmes tags
